CHD5 and gastric neoplasm: Hashimoto et al. in 2020 reported that chromodomain helicase DNA-binding protein 5 (CHD5) in stomach cancer was associated with pathological N status and good prognosis in both overall and recurrence-free survival [74] while also revealing that CHD5 overexpression decreased stomach cancer proliferation and invasion [74].